Correspondence 0001213900-26-002941 from CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC.
Date: Jan. 9, 2026 · CIK: 0001851484 · Accession: 0001213900-26-002941
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292577
Letter
CITIUS ONCOLOGY, INC.
11 Commerce Drive, First Floor
Cranford, NJ 07016
January 9, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
Re:
Acceleration Request Citius Oncology, Inc. Registration Statement on Form S-3 Filed January 5, 2026 File No. 333-292577
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Citius Oncology, Inc. (the "Registrant") hereby requests that the U.S. Securities and Exchange Commission (the "Commission") take appropriate action to accelerate the effective date of the above-referenced registration statement (the "Registration Statement") so as to become effective on Monday, January 12, 2026 at 4:15 p.m. Eastern Time, or as soon thereafter as practicable.
The Registrant hereby authorizes Lorna A. Knick or Christopher Agoranos of Wyrick Robbins Yates & Ponton LLP to orally modify or withdraw this request for acceleration.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Wyrick Robbins Yates & Ponton LLP, by calling Lorna A. Knick or Christopher Agoranos at (919) 781-4000. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Agoranos via email at cagoranos@wyrick.com.
Sincerely,
CITIUS ONCOLOGY, INC.
Show Raw Text
CORRESP 1 filename1.htm CITIUS ONCOLOGY, INC. 11 Commerce Drive, First Floor Cranford, NJ 07016 January 9, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Lauren Hamill Re: Acceleration Request Citius Oncology, Inc. Registration Statement on Form S-3 Filed January 5, 2026 File No. 333-292577 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Citius Oncology, Inc. (the "Registrant") hereby requests that the U.S. Securities and Exchange Commission (the "Commission") take appropriate action to accelerate the effective date of the above-referenced registration statement (the "Registration Statement") so as to become effective on Monday, January 12, 2026 at 4:15 p.m. Eastern Time, or as soon thereafter as practicable. The Registrant hereby authorizes Lorna A. Knick or Christopher Agoranos of Wyrick Robbins Yates & Ponton LLP to orally modify or withdraw this request for acceleration. Once the Registration Statement is effective, please orally confirm the event with our counsel, Wyrick Robbins Yates & Ponton LLP, by calling Lorna A. Knick or Christopher Agoranos at (919) 781-4000. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Agoranos via email at cagoranos@wyrick.com. Sincerely, CITIUS ONCOLOGY, INC. By: /s/ Jaime Bartushak Jaime Bartushak Chief Financial Officer cc: Lorna A. Knick, Wyrick Robbins Yates & Ponton LLP